"Full House" star Dave Coulier revealed this week that he is cancer-free after undergoing chemotherapy following a diagnosis ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

Dave Coulier and his “Full House” family are celebrating the announcement that he has beaten Non-Hodgkin Lymphoma. The actor ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Dave Coulier, best known for Full House, recently opened up about his battle with stage 3 non-Hodgkin’s lymphoma in an ...

Dave Coulier says he is celebrating a significant victory in his health journey after being cancer-free post-diagnosis with ...

In the BRIGHT study, bendamustine plus rituximab was evaluated as a first-line treatment for indolent non-Hodgkin lymphoma or mantle cell lymphoma compared with a standard rituximab-chemotherapy ...

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...

clonoSEQ testing for patients with MCL is currently available for clinical use as a laboratory-developed test performed at Adaptive's CLIA-certified lab in Seattle. clonoSEQ testing in MCL has also ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...